Efficacy, Tolerability, and Safety of Lanthanum Carbonate in Hyperphosphatemia: A 6-Month, Randomized, Comparative Trial versus Calcium Carbonate

Publisher： Karger

E-ISSN： 1660-2110|100|1|c8-c19

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.100, Iss.1, 2005-04, pp. : c8-c19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A comparative review of the efficacy and safety of established phosphate binders: calcium, sevelamer, and lanthanum carbonate

By Sprague Stuart M.  

Current Medical Research and Opinion, Vol. 23, Iss. 12, 2007-12 ,pp. : 3167-3175

Informa Healthcare

Access to resources Recommend Favorite

Long-Term Efficacy and Safety Profile of Lanthanum Carbonate: Results for up to 6 Years of Treatment

By  

Nephron Clin Pract, Vol. 110, Iss. 1, 2008-07 ,pp. : c15-c23

Karger

Access to resources Recommend Favorite

Long-Term Efficacy and Tolerability of Lanthanum Carbonate: Results from a 3-Year Study

By  

Nephron Clin Pract, Vol. 102, Iss. 2, 2005-10 ,pp. : c61-c71

Karger

Access to resources Recommend Favorite

Lanthanum carbonate

By Finn William F  

Therapy, Vol. 2, Iss. 4, 2005-07 ,pp. : 545-557

Future Medicine

Access to resources Recommend Favorite

Sevelamer carbonate in the management of hyperphosphatemia

By Kooienga L   Moore R  

Therapy, Vol. 5, Iss. 4, 2008-07 ,pp. : 545-552

Future Medicine

Access to resources Recommend Favorite